AVEX
OPCH

MADISON DEARBORN PARTNERS LLC

Known title: DirectorCIK: 0001181100

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

RBC Lowers AEVEX Price Target to $26 Amid Naval Contract News. RBC Capital cut its price target for AEVEX to $26 while keeping an Outperform rating, citing investor focus on the 2027 revenue outlook. This follows news that AV’s VideoRay was selected as a subcontractor for a Navy mine countermeasure prototype. The stock is currently trading near its 52-week low of $13.07, reflecting recent pressure despite these developments.

this person other insiders at AVEX

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 11, 2026

McKesson moves to acquire Option Care Health in $5.8B deal. Option Care Health is the target of a $5.8 billion acquisition by McKesson, which has lifted the stock in recent trading. The deal is under legal review, and several analysts have lowered their ratings, with UBS moving to neutral and William Blair to market‑perform. The mixed reactions reflect both the premium offered and the uncertainties around regulatory approval.

this person other insiders at OPCH

Transaction History

AVEX▼ Sell—
AVEX▼ Sell—
AVEX▼ Sell—
AVEX▼ Sell$59.1M
OPCH▼ Sell—
OPCH▼ Sell$0
OPCH▼ Sell$247.5M

We use analytics to understand how market-wall is used. No personal data is sold.